Study of the Efficacy of Triple Therapy of Sofosbuvir, Pegylated INFalpha 2a and Ribavirin in Treatment of Chronic Hepatitis C Patients Genotype 4 with High Fibrosis

ISSN Print: 2163-9450
ISSN Online: 2163-9469
www.scirp.org/journal/ojgas/
E-mail: ojgas@scirp.org

Citations

"Study of the Efficacy of Triple Therapy of Sofosbuvir, Pegylated INFalpha 2a and Ribavirin in Treatment of Chronic Hepatitis C Patients Genotype 4 with High Fibrosis"
written by Alaa Aboud,
published by Open Journal of Gastroenterology, Vol.7 No.1, 2017

has been cited by the following article(s):

[1]	Dual versus triple therapy in treatment of hepatitis C virus (HCV)
	Irish Journal of Medical …, 2022

[2]	Studying the Kynurenine, Some Hematological and Biochemical Changes on Egyptian Patients with Chronic Hepatitis C During and After Treatment with Sofosbuvir
	Benha Journal of …, 2020